Akoya Biosciences Inc (AKYA)
2.14
+0.02
(+0.94%)
USD |
NASDAQ |
Nov 22, 11:53
Akoya Biosciences Enterprise Value: 145.08M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 145.08M |
| November 20, 2024 | 147.06M |
| November 19, 2024 | 147.06M |
| November 18, 2024 | 143.59M |
| November 15, 2024 | 159.45M |
| November 14, 2024 | 195.14M |
| November 13, 2024 | 199.10M |
| November 12, 2024 | 198.11M |
| November 11, 2024 | 199.60M |
| November 08, 2024 | 196.99M |
| November 07, 2024 | 199.47M |
| November 06, 2024 | 200.46M |
| November 05, 2024 | 193.03M |
| November 04, 2024 | 169.76M |
| November 01, 2024 | 175.20M |
| October 31, 2024 | 179.41M |
| October 30, 2024 | 184.61M |
| October 29, 2024 | 181.15M |
| October 28, 2024 | 183.62M |
| October 25, 2024 | 178.67M |
| October 24, 2024 | 182.14M |
| October 23, 2024 | 178.67M |
| October 22, 2024 | 182.14M |
| October 21, 2024 | 189.07M |
| October 18, 2024 | 195.51M |
| Date | Value |
|---|---|
| October 17, 2024 | 191.55M |
| October 16, 2024 | 198.48M |
| October 15, 2024 | 195.01M |
| October 14, 2024 | 198.48M |
| October 11, 2024 | 188.57M |
| October 10, 2024 | 183.13M |
| October 09, 2024 | 190.06M |
| October 08, 2024 | 193.53M |
| October 07, 2024 | 198.97M |
| October 04, 2024 | 177.68M |
| October 03, 2024 | 166.54M |
| October 02, 2024 | 172.73M |
| October 01, 2024 | 179.66M |
| September 30, 2024 | 174.71M |
| September 27, 2024 | 172.03M |
| September 26, 2024 | 164.60M |
| September 25, 2024 | 165.10M |
| September 24, 2024 | 170.05M |
| September 23, 2024 | 167.57M |
| September 20, 2024 | 173.02M |
| September 19, 2024 | 174.50M |
| September 18, 2024 | 171.04M |
| September 17, 2024 | 173.02M |
| September 16, 2024 | 175.99M |
| September 13, 2024 | 175.99M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
109.70M
Minimum
May 23 2024
953.89M
Maximum
Apr 16 2021
341.16M
Average
318.41M
Median
Jul 10 2023
Enterprise Value Benchmarks
| Bruker Corp | 10.71B |
| Azenta Inc | 1.613B |
| Harvard Bioscience Inc | 127.50M |
| Bionano Genomics Inc | 14.35M |
| Singular Genomics Systems Inc | -53.66M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -10.53M |
| Revenue (Quarterly) | 18.81M |
| Total Expenses (Quarterly) | 26.24M |
| EPS Diluted (Quarterly) | -0.21 |
| Gross Profit Margin (Quarterly) | 62.32% |
| Profit Margin (Quarterly) | -55.98% |
| Earnings Yield | -55.14% |
| Normalized Earnings Yield | -50.39 |